Application 021860

Type
NDA
Sponsor
APIL

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SARAFEMFLUOXETINE HYDROCHLORIDETABLET;ORALEQ 10MG BASEYesNo
002SARAFEMFLUOXETINE HYDROCHLORIDETABLET;ORALEQ 15MG BASEYesNo
003SARAFEMFLUOXETINE HYDROCHLORIDETABLET;ORALEQ 20MG BASEYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0430-0210SARAFEMfluoxetine hydrochlorideAllergan, Inc.NDACurrent
0430-0210SARAFEMfluoxetine hydrochlorideAllergan, Inc.NDACurrent
0430-0215SARAFEMfluoxetine hydrochlorideAllergan, Inc.NDACurrent
0430-0220SARAFEMfluoxetine hydrochlorideAllergan, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
68731SUPPL2021-09-23
68678SUPPL2021-09-21
68677SUPPL2021-09-21
46799SUPPL2017-01-11
46798SUPPL2017-01-11
46721SUPPL2017-01-06
45046APPL2016-08-24
45045APPL2016-08-24
16474SUPPL2014-12-03
6324SUPPL2014-12-02
37775SUPPL2013-07-08
37774SUPPL2013-07-08
28729SUPPL2013-07-08
28728SUPPL2013-07-08
28727SUPPL2013-07-08
16473SUPPL2013-07-08
16472SUPPL2013-07-08
6323SUPPL2013-07-08
37773SUPPL2009-04-28
28726SUPPL2009-04-27
42329ORIG2008-09-05
37772SUPPL2007-12-03
28725SUPPL2007-12-03
44157ORIG2007-05-09
28724SUPPL2007-04-09
16471SUPPL2007-04-09
37771ORIG2006-05-22
6322ORIG2006-05-22